Demo Disease Pharma Companies 
H1 Blog
JULY 30, 2024
Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”
H1 Blog
JUNE 7, 2023
Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This is especially true for rare disease populations, where understanding the nuances between different patient cohorts is key to achieving positive outcomes. The Michael J.
H1 Blog
JULY 5, 2023
To learn more about how H1 can help diversify your HCP engagement strategy, request a demo.
Expert insights. Personalized for you.
59 
Let's personalize your content